Genetic and environmental factors as predictors of disease severity and extent at time of diagnosis in an inception cohort of inflammatory bowel disease, Copenhagen County and City 2003-2005

Journal of Crohn's and Colitis

Volumn 2, Issue 2, 2008, Pages 162-169

  Vind, Ida ^a   Riis, Lene ^a   Jespersgaard, Cathrine ^b   Jess, Tine ^a   Knudsen, Elisabeth ^a   Pedersen, Natalia ^a   Elkjaere, Margarita ^a   Hansen, Tanja Stenbaek ^a   Andersen, Inger Bak ^c   Paerregaard, Anders ^a   Bondesen, Stig ^d   Locht, Henning ^b   Larsen, Severin Olesen ^b   Moesgaard, Flemming ^a   Bendtsen, Flemming ^a   Andersen, Paal Skytt ^b   Munkholm, Pia ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b STATENS SERUM INSTITUT   (Denmark)

^c AMAGER HOSPITAL   (Denmark)

^d FREDERIKSBERG HOSPITAL   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

FUNGUS ANTIBODY; NEUTROPHIL CYTOPLASMIC ANTIBODY; SACCHAROMYCES CEREVISIA ANTIBODY;

ADOLESCENT; ADULT; AGED; APPENDECTOMY; ARTICLE; CARD15 GENE; COHORT ANALYSIS; CONTROLLED STUDY; CROHN DISEASE; DISEASE SEVERITY; DLG5 GENE; ENTERITIS; ENVIRONMENTAL EXPOSURE; FEMALE; GENE; GENE MUTATION; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENOTYPE; HAPLOTYPE; HOMOZYGOSITY; HUMAN; MAJOR CLINICAL STUDY; MALE; OCTN GENE; ORAL CONTRACEPTION; PREDICTOR VARIABLE; PRIORITY JOURNAL; PROTEIN LOCALIZATION; QUESTIONNAIRE; SCHOOL CHILD; STATISTICAL SIGNIFICANCE; TONSILLECTOMY; ULCERATIVE COLITIS;

EID: 43449106775     PISSN: 18739946     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.crohns.2008.01.004     Document Type: Article

References (53)

1. Munkholm P., Langholz E., Nielsen O.H., et al. Incidence and prevalence of Crohn's disease in the county of Copenhagen, 1962-87: a sixfold increase in incidence. Scand J Gastroenterol 27 (1992) 609-614
2. Shivananda S., Lennard-Jones J., Logan R., et al. Incidence of inflammatory bowel disease across Europe: is there a difference between north and south? Results of the European Collaborative Study on Inflammatory Bowel Disease (EC-IBD). Gut 39 (1996) 690-697
3. Loftus Jr. E.V. Clinical epidemiology of inflammatory bowel disease: incidence, prevalence, and environmental influences. Gastroenterology 126 (2004) 1504-1517
4. Fonager K., Sorensen H.T., and Olsen J. Change in incidence of Crohn's disease and ulcerative colitis in Denmark. A study based on the National Registry of Patients, 1981-1992. Int J Epidemiol 26 (1997) 1003-1008
5. Moum B., Vatn M.H., Ekbom A., et al. Incidence of ulcerative colitis and indeterminate colitis in four counties of southeastern Norway, 1990-93. A prospective population-based study. The Inflammatory Bowel South-Eastern Norway (IBSEN) Study Group of Gastroenterologists. Scand J Gastroenterol 31 (1996) 362-366
6. Moum B., Vatn M.H., Ekbom A., et al. Incidence of Crohn's disease in four counties in southeastern Norway, 1990-93. A prospective population-based study. The Inflammatory Bowel South-Eastern Norway (IBSEN) Study Group of Gastroenterologists. Scand J Gastroenterol 31 (1996) 355-361
7. Ekbom A., Helmick C., Zack M., et al. The epidemiology of inflammatory bowel disease: a large, population-based study in Sweden. Gastroenterology 100 (1991) 350-358
8. Langholz E., Munkholm P., Nielsen O.H., et al. Incidence and prevalence of ulcerative colitis in Copenhagen county from 1962 to 1987. Scand J Gastroenterol 26 (1991) 1247-1256
9. Tysk C., Lindberg E., Jarnerot G., et al. Ulcerative colitis and Crohn's disease in an unselected population of monozygotic and dizygotic twins. A study of heritability and the influence of smoking. Gut 29 (1988) 990-996
10. Cho J.H., Nicolae D.L., Gold L.H., et al. Identification of novel susceptibility loci for inflammatory bowel disease on chromosomes 1q, 3q, and 4q: evidence for epistasis between 1p and IBD1. Proc Natl Acad Sci U S A 95 (1998) 7502-7507
11. Hugot J.P., Laurent-Puig P., Gower-Rousseau C., et al. Mapping of a susceptibility locus for Crohn's disease on chromosome 16. Nature 379 (1996) 821-823
12. Rioux J.D., Daly M.J., Silverberg M.S., et al. Genetic variation in the 5q31 cytokine gene cluster confers susceptibility to Crohn disease. Nat Genet 29 (2001) 223-228
13. Vermeire S., and Rutgeerts P. Current status of genetics research in inflammatory bowel disease. Genes Immun 6 (2005) 637-645
14. Vind I., Riis L., Jess T., et al. Increasing incidences of inflammatory bowel disease and decreasing surgery rates in Copenhagen City and County, 2003-2005: a population-based study from the Danish Crohn colitis database. Am J Gastroenterol 101 (2006) 1274-1282
15. Langholz E. Ulcerative colitis. An epidemiological study based on a regional inception cohort, with special reference to disease course and prognosis. Dan Med Bull 46 (1999) 400-415
16. Munkholm P. Crohn's disease - occurrence, course and prognosis. An epidemiologic cohort study. Dan Med Bull 44 (1997) 287-302
17. Halfvarson J., Jess T., Magnuson A., et al. Environmental factors in inflammatory bowel disease: a co-twin control study of a Swedish-Danish twin population. Inflamm Bowel Dis 12 (2006) 925-933
18. Corrao G., Tragnone A., Caprilli R., et al. Risk of inflammatory bowel disease attributable to smoking, oral contraception and breastfeeding in Italy: a nationwide case-control study. Cooperative Investigators of the Italian Group for the Study of the Colon and the Rectum (GISC). Int J Epidemiol 27 (1998) 397-404
19. Gasche C., Scholmerich J., Brynskov J., et al. A simple classification of Crohn's disease: report of the Working Party for the World Congresses of Gastroenterology, Vienna 1998. Inflamm Bowel Dis 6 (2000) 8-15
20. Carter M.J., Lobo A.J., and Travis S.P. Guidelines for the management of inflammatory bowel disease in adults. Gut 53 Suppl 5 (2004) V1-V16
21. Miller S.A., Dykes D.D., and Polesky H.F. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 16 (1988) 1215
22. Vind I., Vieira A., Hougs L., et al. NOD2/CARD15 gene polymorphisms in Crohn's disease: a genotype-phenotype analysis in Danish and Portuguese patients and controls. Digestion 72 (2005) 156-163
23. Newman B., Gu X., Wintle R.F., et al. A risk haplotype in the solute carrier family 22A4/22A5 gene cluster influences phenotypic expression of Crohn's disease. Gastroenterology 128 (2005) 260-269
24. Stoll M., Corneliussen B., Costello C.M., et al. Genetic variation in DLG5 is associated with inflammatory bowel disease. Nat Genet 36 (2004) 476-480
25. Wiik A. Antineutrophil cytoplasmic antibodies (ANCAs) and ANCA testing. In: Rose N.R., Hamilton R.G., and Detrick B. (Eds). Manual of clinical and laboratory immunology (2002), ASM Press, Washington DC 981-986
26. Sendid B., Colombel J.F., Jacquinot P.M., et al. Specific antibody response to oligomannosidic epitopes in Crohn's disease. Clin Diagn Lab Immunol 3 (1996) 219-226
27. Peeters M., Cortot A., Vermeire S., et al. Familial and sporadic inflammatory bowel disease: different entities?. Inflamm Bowel Dis 6 (2000) 314-320
28. Hampe J., Grebe J., Nikolaus S., et al. Association of NOD2 (CARD 15) genotype with clinical course of Crohn's disease: a cohort study. Lancet 359 (2002) 1661-1665
29. Riis L.B., Wolters F., Solberg C., et al. Regional differences in the prevalence of single nucleotide polymorphisms in CARD15/NOD2 but not in Toll-like receptor 4 (TLR4) Asp299Gly polymorphism in patients with inflammatory bowel disease (IBD) across Europe: results from the EC-IBD study group. Gastroenterology 126 (2004) A354
30. Jess T., Riis L., Jespersgaard C., et al. Disease concordance, zygosity, and NOD2/CARD15 status: follow-up of a population-based cohort of Danish twins with inflammatory bowel disease. Am J Gastroenterol 100 (2005) 2486-2492
31. Waller S., Tremelling M., Bredin F., et al. Evidence for association of OCTN genes and IBD5 with ulcerative colitis. Gut (2005)
32. Torok H.P., Glas J., Tonenchi L., et al. Polymorphisms in the DLG5 and OCTN cation transporter genes in Crohn's disease. Gut 54 (2005) 1421-1427
33. Noble C.L., Nimmo E.R., Drummond H., et al. The contribution of OCTN1/2 variants within the IBD5 locus to disease susceptibility and severity in Crohn's disease. Gastroenterology 129 (2005) 1854-1864
34. Daly M.J., Pearce A.V., Farwell L., et al. Association of DLG5 R30Q variant with inflammatory bowel disease. Eur J Hum Genet 13 (2005) 835-839
35. Noble C.L., Nimmo E.R., Drummond H., et al. DLG5 variants do not influence susceptibility to inflammatory bowel disease in the Scottish population. Gut 54 (2005) 1416-1420
36. Quinton J.F., Sendid B., Reumaux D., et al. Anti-Saccharomyces cerevisiae mannan antibodies combined with antineutrophil cytoplasmic autoantibodies in inflammatory bowel disease: prevalence and diagnostic role. Gut 42 (1998) 788-791
37. Sandborn W.J., Loftus Jr. E.V., Colombel J.F., et al. Evaluation of serologic disease markers in a population-based cohort of patients with ulcerative colitis and Crohn's disease. Inflamm Bowel Dis 7 (2001) 192-201
38. Vermeire S., Peeters M., Vlietinck R., et al. Anti-Saccharomyces cerevisiae antibodies (ASCA), phenotypes of IBD, and intestinal permeability: a study in IBD families. Inflamm Bowel Dis 7 (2001) 8-15
39. Hansen T.S., Vind I., Elkjaer M., et al. Environmental factors in development of inflammatory bowel disease: a case-control study based on the Copenhagen IBD incidence cohort 2003-2004 (2007) A127
40. Calkins B.M. A meta-analysis of the role of smoking in inflammatory bowel disease. Dig Dis Sci 34 (1989) 1841-1854
41. Cosnes J., Beaugerie L., Carbonnel F., et al. Smoking cessation and the course of Crohn's disease: an intervention study. Gastroenterology 120 (2001) 1093-1099
42. Thomas G.A., Rhodes J., and Ingram J.R. Mechanisms of disease: nicotine-a review of its actions in the context of gastrointestinal disease. Nat Clin Pract Gastroenterol Hepatol 2 (2005) 536-544
43. Hallas J., Gaist D., and Sorensen H.T. Does appendectomy reduce the risk of ulcerative colitis?. Epidemiology 15 (2004) 173-178
44. Andersson R.E., Olaison G., Tysk C., et al. Appendectomy is followed by increased risk of Crohn's disease. Gastroenterology 124 (2003) 40-46
45. Andersson R.E., Olaison G., Tysk C., et al. Appendectomy and protection against ulcerative colitis. N Engl J Med 344 (2001) 808-814
46. Mayberry J.F., Rhodes J., and Newcombe R.G. Increased sugar consumption in Crohn's disease. Digestion 20 (1980) 323-326
47. Reif S., Klein I., Lubin F., et al. Pre-illness dietary factors in inflammatory bowel disease. Gut 40 (1997) 754-760
48. Thornton J.R., Emmett P.M., and Heaton K.W. Diet and Crohn's disease: characteristics of the pre-illness diet. Br Med J 2 (1979) 762-764
49. Danese S., Sans M., and Fiocchi C. Inflammatory bowel disease: the role of environmental factors. Autoimmun Rev 3 (2004) 394-400
50. Timmer A., Sutherland L.R., Martin F., et al. Oral contraceptive use and smoking are risk factors for relapse in Crohn's disease. Gastroenterology 114 (1998) 1143-1150
51. Cosnes J., Carbonnel F., Carrat F., et al. Oral contraceptive use and the clinical course of Crohn's disease: a prospective cohort study. Gut 45 (1999) 218-222
52. Mate-Jimenez J., Correa-Estan J.A., Perez-Miranda M., et al. Tonsillectomy and inflammatory bowel disease location. Eur J Gastroenterol Hepatol 8 (1996) 1185-1188
53. Mayberry J.F., Rhodes J., Allan R., et al. Diet in Crohn's disease two studies of current and previous habits in newly diagnosed patients. Dig Dis Sci 26 (1981) 444-448